Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

GLP-1 drugs used for weight loss involve all kinds of side effects ... include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and Zepbound (tirzepatide).) ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies, ...